Abstract Details

Title A Prospective Randomized Double-Blind and Placebo Controlled Phase II Trial - Effect of CoQ 10 on Statin Induced Mitochondrial Dysfunction

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 254

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Naganand Sripathi, MD (Henry Ford Hospital)	Dr. Sripathi has nothing to disclose.
Angel Vinuela Cabezas De Herrera, MD (Columbia University)	No disclosure on file
Kavita M. Grover, MD, FAAN	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
	No disclosure on file
	No disclosure on file
Mei Lu, MD (cleveland clinic)	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��